Yinhuang Injection

Yinhuang Injection is a traditional Chinese medicine (TCM) injectable preparation developed and manufactured by Sichuan Sunnyhope Pharmaceutical. It is formulated from the extracts of two primary medicinal herbs: *Lonicera japonica* (honeysuckle) and *Scutellaria baicalensis* (skullcap). The injection is widely utilized in clinical practice in China for the treatment of various inflammatory and infectious conditions, including upper respiratory tract infections, acute tonsillitis, and pharyngitis. Its therapeutic profile is characterized by a combination of antibacterial, antiviral, and anti-inflammatory activities, which are attributed to its key active components, chlorogenic acid and baicalin. As a marketed product, it is part of the essential medicine series in China and is typically administered via intramuscular injection to achieve rapid systemic effects.

Brand names

Yinhuang Injection

Other names

银黄注射液Yinhuang Zhusheye